Fluicell Receives a New Patent Acceptance for the BioPen System

Monday, July 24, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

STOCKHOLM, July 24, 2017 /PRNewswire/ -- Fluicell AB, a pioneering high-tech company in single-cell biology, is extremely

delighted to announce the issuance of US Patent No 9,6719,671,366, entitled "Pipettes, methods of use, and methods of stimulating an object of interest", by the USPTO.

This is the third patent issued to Fluicell AB, representing a continued advancement

of their innovative BioPen system. This platform facilitates complex cell biology experiments at the single-cell level, at affordable prices.

This approval gives further recognition to the Fluicell team as innovation leaders, and solution providers for cell biology research and discovery tools for the 21st century.

For further information, please visit us at fluicell.com or contact:

Victoire ViannayCEOTel: +46-725-65-42-05E-mail: [email protected]

About Fluicell

Fluicell is an exciting Swedish high-tech company that brings inspiration and innovation to life science researchers around the globe. Fluicell provides innovative tools with outstanding performance, redefining approaches within; cell biology, bioprinting, and secondary drug screening and discovery. Fluicell strives for technology solutions which are environmentally friendly, sustainable, and that ultimately reduces costs, resource use, and animals. Fluicell's main target sectors include universities, the pharmaceutical industry, and national health laboratories. 

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/fluicell/r/fluicell-receives-a-new-patent-acceptance-for-the-biopen-system,c2315287

View original content:http://www.prnewswire.com/news-releases/fluicell-receives-a-new-patent-acceptance-for-the-biopen-system-300492711.html

SOURCE Fluicell



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store